Metropolitan Life Insurance CO Paratek Pharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.81 - $10.93 $81 - $131	-12 Closed	0 $0
Q1 2021 Jun 26, 2023	BUY	$6.14 - $8.31 $74,981 - $101,481	12,212 New	12,212 $86.2 Million
Q1 2021 Mar 30, 2023	SELL	$6.14 - $8.31 $13,999 - $18,946	-2,280 Reduced 15.73%	12,212 $86,000
Q1 2021 May 14, 2021	SELL	$6.14 - $8.31 $88,907 - $120,328	-14,480 Reduced 99.92%	12 $86,000
Q4 2020 Jun 22, 2023	BUY	$4.58 - $7.14 $66,373 - $103,472	14,492 New	14,492 $90,000
Q4 2020 Mar 30, 2023	SELL	$4.58 - $7.14 $293 - $456	-64 Reduced 0.44%	14,492 $90,000
Q4 2020 Feb 16, 2021	SELL	$4.58 - $7.14 $293 - $456	-64 Reduced 0.44%	14,492 $91,000
Q3 2020 Jun 26, 2023	BUY	$4.19 - $6.69 $60,989 - $97,379	14,556 New	14,556 $78,000
Q3 2020 Mar 30, 2023	SELL	$4.19 - $6.69 $1,139 - $1,819	-272 Reduced 1.83%	14,556 $78,000
Q3 2020 Nov 13, 2020	SELL	$4.19 - $6.69 $1,139 - $1,819	-272 Reduced 1.83%	14,556 $79,000
Q2 2020 Jun 26, 2023	BUY	$2.97 - $5.22 $44,039 - $77,402	14,828 New	14,828 $77,000
Q2 2020 Mar 30, 2023	BUY	$2.97 - $5.22 $44,039 - $77,402	14,828 New	14,828 $77,000
Q2 2020 Aug 14, 2020	BUY	$2.97 - $5.22 $44,039 - $77,402	14,828 New	14,828 $77,000
Q4 2018 Feb 14, 2019	SELL	$4.8 - $11.6 $12,043 - $29,104	-2,509 Closed	0 $0
Q3 2018 Jul 13, 2023	BUY	$9.05 - $10.95 $133,578 - $161,622	14,760 New	14,760 $143 Million
Q3 2018 Nov 14, 2018	SELL	$9.05 - $10.95 $110,871 - $134,148	-12,251 Reduced 83.0%	2,509 $24,000
Q2 2018 Aug 15, 2018	BUY	$10.2 - $13.9 $67,575 - $92,087	6,625 Added 81.44%	14,760 $0
Q4 2017 Feb 15, 2018	SELL	$17.45 - $25.6 $125,535 - $184,166	-7,194 Reduced 46.93%	8,135 $146,000
Q2 2017 Aug 14, 2017	BUY	N/A	15,329	15,329 $369,000

Others Institutions Holding PRTK

# of Institutions

Shares Held

1.54M

Call Options Held

Put Options Held

View Full List

About Paratek Pharmaceuticals, Inc.

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

More about PRTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account